Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research



Rating:

Share or cite this content

Citations should be made in the following way:
B. Ding (Gothenburg, Sweden), S. Chen (Gaithersburg, Maryland, United States of America), A. Agrawal (New Delhi, India), D. Srivastava (Pune, India), J. Solorzano (Cambridge, United Kingdom), B. Cook (Gaithersburg, Maryland, United States of America), A. Papi (Ferrara, Italy), H. Reddel (Sydney, Australia). Distribution of biomarkers in severe asthma and severe uncontrolled asthma. 4214

Member's Comments

No comment yet.

Related content which might interest you: Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Genetic comparison between severe persistent asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003 Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Assessing severe asthma Source: Eur Respir J 2016; 48: 611-613 Year: 2016 Ykl-40 and phenotyping of severe asthma Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Identifying asthma features in severe COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Markers of severity and inflammatory profile during exacerbations of severe asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Only severe asthma? Source: International Congress 2019 – PG11 Severe paediatric asthma Year: 2019 Pathophysiology of severe asthma phenotypes Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 Evolution from mild to severe asthma; the severe asthma clinic perspective Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Factors resulting in uncontrolled severe persistent asthma in children Source: Eur Respir J 2004; 24: Suppl. 48, 20s Year: 2004 Difficult-to-treat and severe asthma Source: Breathe 2014; 10: 91-94 Year: 2014 Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021 Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma Source: Eur Respir J, 58 (6) 2100413; 10.1183/13993003.00413-2021 Year: 2021 Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma Source: Eur Respir J 2002; 19: 846-852 Year: 2002 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005